India Seeks a Healthcare Breakthrough on the Scale of Chandrayaan-3

India is now looking to reproduce the ambition of Chandrayaan-3 in healthcare, with the Indian Council of Medical Research (ICMR) challenging scientists and innovators to develop medical technologies that have never been achieved anywhere in the world. The initiative, called the “First in the World Challenge,” targets breakthrough vaccines, drugs, therapeutics, diagnostics and other biomedical technologies. 

From the Moon to Medicine

Chandrayaan-3 demonstrated India's ability to pursue a technically difficult objective and achieve a historic first. ICMR says that success inspired its healthcare innovation programme, which is designed to encourage researchers to attempt similarly ambitious problems in biomedical science. 

The objective is not simply to improve an existing medical product. The programme specifically seeks technologies that have not previously been thought of, tested or tried anywhere in the world. 

Up to ₹8 Crore for a Single Project

ICMR has structured the funding in stages, allowing projects to progress from an idea to a potentially deployable technology.

The funding can reach:

• Up to ₹1 crore for proof-of-concept development
• Up to ₹4 crore for prototype development
• Up to ₹8 crore for a final product or implementation model

Funding at each stage is linked to deliverables, with ICMR reviewing progress before deciding whether a project should move to the next stage. 

What Kind of Breakthroughs Is India Looking For?

The challenge covers a wide range of biomedical innovation, including:

• New vaccines
• Drugs and therapeutics
• Advanced diagnostics
• Medical interventions
• Biomedical technologies
• Other potentially transformative healthcare solutions

The emphasis is on high-risk, high-reward research, meaning some projects may fail. ICMR's stated objective is that successful projects could produce major advances in biomedical science and healthcare. 

Startups Can Also Apply

The programme is not restricted to government scientists.

Researchers from government medical colleges, Institutes of National Importance, universities and recognised research laboratories can apply. Eligible Indian startups, MSMEs, industry and certain NGOs are also included. 

This opens the programme to collaboration between scientists, hospitals, universities and India's growing health-technology sector.

How Will ICMR Decide What Is Truly New?

A proposal first has to establish that its proposed technology genuinely qualifies as “First in the World.”

After that, a selection committee involving experts, innovators, policymakers and scientists will assess factors including relevance and potential impact. Researchers must also explain the clinical need, advantages over existing approaches and how the technology could eventually move toward validation, regulation, commercialisation and deployment. 

Applications Open in October

For the 2026 call, ICMR says the application window opens on October 7, 2026, and closes on November 30, 2026, at 5:30 PM. Results are scheduled for December 31, 2026. 

ICMR's website currently lists the programme among its active calls for research proposals. 

Healthcare Innovation Is Expanding

The First in the World Challenge is part of a broader push to strengthen India's biomedical research ecosystem.

The government says ICMR's health-research allocation has risen to ₹4,000 crore for 2026–27, while its wider research framework includes grants for investigator-led research, high-risk innovation and advanced research centres. 

The 2026 Budget has also proposed ₹10,000 crore over five years for Biopharma SHAKTI, aimed at strengthening India's biologics and biosimilars ecosystem and supporting research, clinical trials and manufacturing. 

Why It Matters

India has already built significant capabilities in affordable medicines, vaccines, digital health and biomedical research. The next challenge is moving further toward original discoveries and technologies that can change how diseases are diagnosed or treated.

A successful project under the programme would not automatically equal a Chandrayaan-3-scale achievement. But the comparison reflects the ambition: to encourage Indian researchers to pursue globally unprecedented scientific goals rather than limiting research to incremental improvements.

What Happens Next

The immediate test will be the quality of proposals submitted after the October 7 opening.

The difficult part will come later: turning promising ideas into validated technologies that are safe, effective, affordable and capable of reaching patients. Scientific discovery alone does not guarantee successful clinical deployment.

TVR Perspective

India's healthcare challenge is moving beyond simply expanding access to existing treatments. The First in the World Challenge signals an attempt to push Indian biomedical research toward original, globally significant discoveries. The real measure of success will ultimately be whether laboratory breakthroughs can become safe, affordable and widely usable healthcare solutions.

Sources & Verification

The programme details, eligibility, funding stages and 2026 application timeline were verified against the Indian Council of Medical Research's official 2026 call and ICMR's website. The broader health-research funding figures were checked against Government of India releases. 

About TVR

TVR: The Voice Of Reform is an independent digital news platform covering major developments across India and around the world.

Editorial Note

Our articles are prepared using publicly available information and verified reporting. We aim to present news accurately, independently and responsibly. Information may be updated as new facts emerge.

© 2026 TVR: The Voice Of Reform. All Rights Reserved.